1. Comparative characterisation of Covid-19 patients with hypertension comorbidity in Malawi: A 1:2 Matched Retrospective Case Control Study
- Author
-
Collins Mitambo, Pizga Kumwenda, Billy Nyambalo, Balwani Chingatichifwe Mbakaya, Saul Eric Mwale, and Master Chisale
- Subjects
medicine.medical_specialty ,hypertension ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Case-control study ,Signs and symptoms ,medicine.disease ,Comorbidity ,mortality ,Article ,Liver disease ,case control ,Internal medicine ,Health care ,Medicine ,Proper treatment ,risk factors ,Risk of death ,business ,Covid-19 - Abstract
Objective The aim of this study was to characterize Covid-19 cases and explore risk factors associated with mortality among hypertensive patients with COVID-19 country-wide. Methods We used a retrospective case control study design to provide a detailed account of cases and explore risk factors associated with mortality among hypertensive patients with COVID-19 country-wide. A total of 441 patients were included in the study in the ratio of one case to two controls (1:2), matched by age. Results Deaths due to Covid-19 varied with hypertensive condition with more deaths registered in hypertensive patients. Clinical signs and symptoms in Covid-19 patients varied greatly between hypertensive and non-hypertensive patients, with a leaning favouring the latter. The risk of death due to Covid-19 among hypertensive patients increased with age and meaningfully associated with underlining comorbidities such as HIV, TB, cardiovascular, and liver disease. Conclusion Our study reveals predictive factors for mortality in COVID-19 hypertensive patients that can be used by policy makers and health care practioners to identify those at a higher risk and determine proper treatment approach to achieve best possible clinical outcomes.
- Published
- 2021